Abstract: Six of the seven significant
core mutations that were identified in this study were located within immuno-active epitopes;
E77Q,
A80I/T/V, and
L116I were located within B-cell epitopes, and
F24Y,
E64D, and
V91S/T were located within T-cell epitopes.
Result: Furthermore, mutation
V91T, substituting valine for threonine at the same
core position as
V91S, was present in large percentage of patients in the AC+
LC+
HCC group; this prevalence (91.12%) was significantly higher than was seen in the IC group (9.44%; p < 0.0001).|mgd